We were incorporated in Delaware under the name Blue Acquisition Corp. in December 2006 and changed our name to Pacira, Inc. in June 2007. In October 2010, we changed our name to Pacira Pharmaceuticals, Inc.
Pacira went public on February 3, 2011 at a price of $7.00 per share.
Pacira does not currently pay a dividend to holders of its common stock.
Pacira common stock trades on the NASDAQ Global Select Stock Market under the ticker PCRX.
Computershare
462 South 4th Street Suite 1600
Louisville, KY 40202
(800) 962-4284
http://www.computershare.com/us
462 South 4th Street Suite 1600
Louisville, KY 40202
(800) 962-4284
http://www.computershare.com/us
You should review our public filings with the Securities and Exchange Commission that are available from our SEC Filings page or at www.sec.gov. These filings, including our most recent Annual Report on Form 10-K and any subsequent reports on Form 10-Q, contain important information regarding risks that could significantly and negatively affect our business and the trading price of our common stock.
Reports are available for download from our SEC Filings page; hard copies can be requested on our Information Request page.
No, Pacira does not have a program for the direct purchase of stock.
No, Pacira has not had any stock splits since going public.
Please see our Event Calendar page.
 |
